newsfilter
← Latest News
Business Wire·

Sesen Bio Reports Second Quarter 2021 Financial Results and Significant Global Progress for Vicineum™

The Company believes it remains on track for an FDA decision on its BLA for Vicineum by August 18, 2021 The Company also believes it remains on track for potential approval in Europe and key markets in MENA in 2022 Strengthened balance sheet with